Since our analyses with Fe65 truncation mutants were performed under overexpression conditions, it is important to point out that our studies do not exclude the possibility that the ability of Fe65 to regulate breast cancer invasion may be sensitive to cellular status of Mena. The gene discussed is ENAH; the disease is breast carcinoma.